Opportunity ID: 331326

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DA-22-006
Funding Opportunity Title: High-throughput Discovery and Validation of Novel Signal Transducers or Small Molecules that Modulate Opioid or other Substance Use Disorder Relevant Pathways (R01 – Clinical Trials Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.279 — Drug Abuse and Addiction Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Feb 04, 2021
Last Updated Date: Feb 04, 2021
Original Closing Date for Applications: Sep 15, 2021
Current Closing Date for Applications: Sep 15, 2021
Archive Date: Oct 21, 2021
Estimated Total Program Funding:
Award Ceiling: $400,000
Award Floor:

Eligibility

Eligible Applicants: Public and State controlled institutions of higher education
Public housing authorities/Indian housing authorities
Private institutions of higher education
Native American tribal governments (Federally recognized)
County governments
State governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Special district governments
For profit organizations other than small businesses
Small businesses
City or township governments
Independent school districts
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This FOA will support high-throughput screening or similar transformative approaches to identify novel receptors, signal transducers, or small molecules that modulate SUD-relevant signal transduction pathways (dopamine, opioid, cannabinoid, nicotinic, or other appropriately justified pathway). These projects may also include secondary screens and/or validation of key hits identified.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-006.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-F Use for due dates on or after May 25, 2020 PKG00265296 Aug 15, 2021 Sep 15, 2021 View

Package 1

Mandatory forms

331326 RR_SF424_2_0-2.0.pdf

331326 PHS398_CoverPageSupplement_5_0-5.0.pdf

331326 RR_OtherProjectInfo_1_4-1.4.pdf

331326 PerformanceSite_2_0-2.0.pdf

331326 RR_KeyPersonExpanded_2_0-2.0.pdf

331326 PHS398_ResearchPlan_4_0-4.0.pdf

331326 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

331326 RR_Budget_1_4-1.4.pdf

331326 RR_SubawardBudget30_1_4-1.4.pdf

331326 PHS398_ModularBudget_1_2-1.2.pdf

331326 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-11T05:31:57-05:00

Share This Post, Choose Your Platform!

About the Author: